Upper Gastrointestinal Safety with the Buffered Solution of Alendronate 70mg: Postmarketing Experience.

被引：0
|
作者：
Hruska, Josef [1 ]
Jorgensen, Flemming Kjaer [2 ]
Eriksen, Erik Fink [3 ]
机构：
[1] MeDACom GmbH, Bern, Switzerland
[2] KLIFO AS, Glostrup, Denmark
[3] Oslo Univ Hosp, Oslo, Norway
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2017年 / 32卷
关键词：
OSTEOPOROSIS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SU0292
引用
收藏
页码：S269 / S269
页数：1
相关论文
共 50 条
  • [1] UPPER GASTROINTESTINAL SAFETY WITH THE BUFFERED SOLUTION OF ALENDRONATE 70 MG: POST-MARKETING EXPERIENCE
    Hruska, J.
    Jorgensen, F. K.
    Pierleoni-Nielsen, C.
    Eriksen, E. F.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S366 - S366
  • [2] UPPER GASTROINTESTINAL SAFETY WITH THE BUFFERED SOLUTION OF ALENDRONATE 70 MG: 6 YEARS OF POST-MARKETING EXPERIENCE
    Fardellone, P.
    Boezennec, B.
    Cortet, B.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S483 - S484
  • [3] Persistence with Buffered Solution of Alendronate 70mg: Prospective Observational Study
    Giusti, Andrea
    Black, Dennis M.
    Barone, Antonella
    Hruska, Josef
    Bianchi, Gerolamo
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 174 - 175
  • [4] Two-year gastrointestinal safety and tolerability of alendronate 70mg once weekly.
    Genco, RJ
    Van Dyke, T
    Leung, A
    Meng, L
    Ritter, S
    Grossman, S
    Salzmann, G
    Lombardi, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S528 - S528
  • [5] Effect of Buffered Solution of Alendronate 70mg on Bone Mineral Density and Bone ALP: Prospective Observational Study
    Giusti, Andrea
    Black, Dennis M.
    Barone, Antonella
    Hruska, Josef
    Bianchi, Gerolamo
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 286 - 286
  • [6] Early effects and safety of alendronate (Fosamax®) 70mg once weekly (EASY).
    Djandji, M
    Sampalis, JS
    Karaplis, AC
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S312 - S312
  • [7] PERSISTENCE WITH THE BUFFERED SOLUTION OF ALENDRONATE 70 MG: PROSPECTIVE OBSERVATIONAL STUDY
    Giusti, A.
    Bianchi, G.
    Barone, A.
    Hruska, J.
    Black, D. M.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S431 - S431
  • [8] APPRECIATION OF OSTEOPOROTIC TREATMENT COMPLIANCE WITH ALENDRONATE 70MG ORALLY
    Bengana, Bilal
    Boukabous, Abdenour
    Bahaz, Naima
    Lefkir, Salima
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1882 - 1882
  • [9] A Prospective Open-Label Observational Study Of a Buffered Soluble 70 mg Alendronate Effervescent Tablet On Upper Gastrointestinal Safety and Medication Errors: the GastroPASS Study
    Minisola, Salvatore
    Vargas, Antonio Ponce
    Mauro, Giulia Letizia
    Madurga, Fernando Bonet
    Adami, Giovanni
    Black, Dennis M.
    Qizilbash, Nawab
    Blanch-Rubio, Josep
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 311 - 311
  • [10] A Prospective Open-Label Observational Study of a Buffered Soluble 70 mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The GastroPASS Study
    Minisola, Salvatore
    Vargas, Antonio P.
    Mauro, Giulia Letizia
    Madurga, Fernando Bonet
    Adami, Giovanni
    Black, Dennis M.
    Qizilbash, Nawab
    Blanch-Rubio, Josep
    JBMR PLUS, 2021, 5 (07)
12345